$MCBS

METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR SECOND QUARTER 2026

MetroCity Bankshares (NASDAQ: MCBS) reported Q2 2026 net income of $22.1 million, or $0.76 per diluted share, down from $22.3 million, or $0.77, in Q1 2026 and up from $16.8 million, or $0.65, in Q2 2025. Net interest margin rose to 4.11% from 4.08% in Q1. For six months ended June 30, 2026, net income was $44.4 million, or $1.53 per share.

Original reporting
Published Jul 24, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 24, 2026, 10:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR SECOND QUARTER 2026 — source image
Decision brief

The 30-second read

$MCBSNeutralMed
01

Why it matters

Traders can reassess near-term earnings power using the disclosed NIM (4.11% QoQ up 3 bps) and efficiency ratio (40.08% QoQ up), plus the stated drivers (SBA servicing income down, tax expense up, gain on sale up).

02

Market read

Company-specific earnings datapoints with clear QoQ and YoY drivers, useful for modeling NIM and cost efficiency into the next few quarters.

03

What to watch

The excerpt highlights derivative hedges and SBA loan sales premiums, but does not include credit quality, deposit mix, or management guidance, which are often the real drivers of bank stock repricing.

Relevance 6/10Novelty 6/10Timing: after-hours earnings release for Q2 2026 (published 2026-07-24 21:15 UTC)

Background

MetroCity Bankshares is a bank holding company; this PRNewswire release reports Q2 2026 results and key operating metrics (NIM, efficiency, ROA/ROE) with variance explanations.

Company-level read

Ticker impact

$MCBSNeutralMedium confidence
Context

MetroCity Bankshares reported Q2 2026 net income of $22.1M and net interest margin of 4.11%, with detailed drivers vs prior quarters.

Expected impact

Likely modest, range-bound reaction unless investors focus on NIM trajectory and efficiency ratio deterioration QoQ.

Evidence & confidence

The release provides full quarterly datapoints (net income, NIM, efficiency, interest income/expense drivers) but no guidance, capital actions, or balance-sheet credit quality metrics in the provided excerpt.

Market effects

Adds another datapoint on small/mid-cap bank profitability drivers, especially NIM sensitivity and SBA-related servicing income.

Limited, as the story is company-specific to MetroCity’s operations.

Low; no cross-border or macro policy linkage beyond general interest-rate derivative hedging disclosures.

Counterpoint

QoQ net income fell and efficiency ratio rose, so the improved NIM vs last year may not translate into sustained earnings momentum without cost control.

Key entities

  • MetroCity Bankshares, Inc.

    NASDAQ-listed holding company reporting Q2 2026 earnings and operating metrics.

  • Metro City Bank

    Operating bank within the holding company referenced in the release.

  • First IC Corporation

    Acquisition completed in Q4 2025, cited as a driver of year-over-year net income growth.

Related articles

$MCBSMed

MetroCity Bankshares, Inc. (MCBS): Results of Operations and Financial Condition

MetroCity Bankshares, Inc. (MCBS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mcbs-20260724xex99d1.htm EX-99.1 Exhibit 99.1 ​ FOR IMMEDIATE RELEASE ​ ​ METROCITY BANKSHARES, INC. REPORTS EARNINGS FOR SECOND QUARTER 2026 ​ ATLANTA, GA (July 24, 2026) – MetroCity Bankshares, Inc. (“MetroCity” or the “Company”) (NASDAQ: MCBS), holding company for Me

$NMAXMed

Newsmax (NMAX) Q2 2026 Earnings Call Transcript

Newsmax (NMAX) reported Q2 2026 revenue of $54.1M, up 16.5% YoY. Key growth drivers were affiliate fees (up 81.9%) and licensing (up 557.1%). Net income was $2.9M, the first profitable quarter as a public company. The company highlighted audience growth, international expansion, and a strategic AI partnership with Meta. Full-year revenue guidance was reiterated at $212M-$216M.

$LITEHighAI 9/10

Lumentum Is Winning AI Stock's Next Big Infrastructure Bottleneck

Lumentum Holdings (LITE) reported fiscal Q4 revenue of $1B, up 109% YoY, with adjusted EPS at $3.23. Guidance for Q1 suggests 134% YoY revenue growth to $1.25B. NVIDIA invested $2B in Lumentum for optical components crucial for AI data centers, highlighting supply-demand imbalances. Analysts predict strong growth but note risks like AI spending slowdowns.

$BEKEMedAI 8/10

KE Holdings (BEKE) Q2 2026 Earnings Call Transcript

KE Holdings (BEKE) reported Q2 2026 results with GTV up 6.3% YoY, non-GAAP net income up 74.9% YoY to RMB 3.2B, and gross margin at 28.6%. Revenue declined in home renovation and rental but improved in existing and new home segments. The company repurchased $250M in shares and maintained a cash balance of RMB 67.3B. Management highlighted cost optimizations and strategic shifts.

$HKHCHighAI 8/10

Horizon Kinetics Holding Corp (HKHC) (Q2 2026) Earnings Call Highlights: Navigating

Horizon Kinetics Holding Corp (HKHC) reported a Q2 2026 net loss of $18.4M, or $0.99 per share, due to unrealized investment losses. Revenues from mutual funds fell 17% YoY, while operating expenses rose 5.5%. AUM dropped to $10.8B, impacted by declines in TPL and bitcoin-related holdings. The company plans to launch targeted marketing for ETFs and invest in AI data center resources. GAAP net income for H1 2026 was $54.2M, boosted by Q1 performance fees.

$SPRYMedAI 8/10

ARS Pharma (SPRY) Q2 2026 Earnings Call Transcript

ARS Pharma (SPRY) reported Q2 2026 U.S. net product revenue of $26.2M, with total market share reaching 5%, up from 2.5% YoY. Neffy's market share in targeted areas hit 8%, driven by 16,000+ unique prescribers. The company aims to expand into the CSU market and expects cash flow breakeven by late 2027. Total revenue was $33.7M, with operating expenses at $95.1M. ARS plans to reduce SG&A and R&D expenses by over 40% in the second half of 2026.